We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The number of NIH grants for small businesses conducting research declined steadily from fiscal 2004 through 2006 and is projected to drop further in light of expected budget requests for fiscal 2007 and 2008, according to data provided by the agency.
The Bush administration is cautioning critics of the FDA budget to consider the agency’s long-term plans when assessing the fiscal 2008 budget proposal.
The Bush administration is cautioning critics of the FDA budget to consider the agency’s long-term plans when assessing the fiscal 2008 budget proposal.
In a development likely to fuel the argument that Medicare and Medicaid need major overhauls, the Congressional Budget Office (CBO) is predicting that these programs will grow by 124 percent over the next 10 years, outpacing economic growth two to one.
The FDA is focusing on improved use of epidemiological data and assessment of risk management plans (RMP) as two of the touchstones of its ongoing Prescription Drug User Fee Act (PDUFA) negotiations, a high-ranking agency official said.
A controversial amendment to a House appropriations bill giving the FDA new authority to require postmarket studies was stripped from the legislation, while another divisive provision eliminating conflict-of-interest waivers for advisory boards lives on.